Literature DB >> 24868320

Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations.

Robert J Wong1, Aijaz Ahmed1.   

Abstract

Obesity is a global epidemic contributing to an increasing prevalence of obesity-related systemic disorders, including nonalcoholic fatty liver disease. The rising prevalence of nonalcoholic steatohepatitis (NASH) will in the near future lead to end-stage liver disease in a large cohort of patients with NASH-related cirrhosis and NASH is predicted to be a leading indication for liver transplantation in the coming decade. However, the prevalence of obesity and the progression of hepatic histological damage associated with NASH exhibit significant ethnic disparities. Despite a significantly lower body mass index and lower rates of obesity compared to other ethnic groups, Asians continue to demonstrate a significant prevalence of hypertension, diabetes, metabolic syndrome and NASH. Ethnic disparities in central adiposity and visceral fat distribution have been hypothesized to contribute to these ethnic disparities. The current review focuses on the epidemiology of obesity and NASH among Asian populations.

Entities:  

Keywords:  Asians; Hepatocellular carcinoma; Metabolic syndrome; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Obesity

Year:  2014        PMID: 24868320      PMCID: PMC4033284          DOI: 10.4254/wjh.v6.i5.263

Source DB:  PubMed          Journal:  World J Hepatol


  114 in total

1.  Identifying patients for weight-loss treatment: an empirical evaluation of the NHLBI obesity education initiative expert panel treatment recommendations.

Authors:  M Kiernan; M A Winkleby
Journal:  Arch Intern Med       Date:  2000-07-24

2.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

3.  Change in body mass index and its impact on blood pressure: a prospective population study.

Authors:  W B Drøyvold; K Midthjell; T I L Nilsen; J Holmen
Journal:  Int J Obes (Lond)       Date:  2005-06       Impact factor: 5.095

4.  Body mass index and the prevalence of hypertension and dyslipidemia.

Authors:  C D Brown; M Higgins; K A Donato; F C Rohde; R Garrison; E Obarzanek; N D Ernst; M Horan
Journal:  Obes Res       Date:  2000-12

5.  Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.

Authors:  Shih-Wei Lai; Pei-Chun Chen; Kuan-Fu Liao; Chih-Hsin Muo; Cheng-Chieh Lin; Fung-Chang Sung
Journal:  Am J Gastroenterol       Date:  2011-11-15       Impact factor: 10.864

6.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

7.  Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.

Authors:  Maria Stepanova; Nila Rafiq; Zobair M Younossi
Journal:  Gut       Date:  2010-07-26       Impact factor: 23.059

8.  Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.

Authors:  Yung Seng Lee; Betty Lay Kee Kek; Larry Kok Seng Poh; Seang Mei Saw; Kah Yin Loke
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-08       Impact factor: 2.839

9.  Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease.

Authors:  Chung-Huang Tsai; Tsai-Chung Li; Cheng-Chieh Lin
Journal:  South Med J       Date:  2008-09       Impact factor: 0.954

10.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.

Authors:  David E Laaksonen; Hanna-Maaria Lakka; Leo K Niskanen; George A Kaplan; Jukka T Salonen; Timo A Lakka
Journal:  Am J Epidemiol       Date:  2002-12-01       Impact factor: 4.897

View more
  35 in total

1.  Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Prior to Abdominal Operation: a Retrospective Analysis.

Authors:  Adam Schmitz; Paul Haste; Matthew S Johnson
Journal:  J Gastrointest Surg       Date:  2019-09-04       Impact factor: 3.452

Review 2.  Hepatocellular Carcinoma: Etiology and Current and Future Drugs.

Authors:  Aastha Jindal; Anusha Thadi; Kunwar Shailubhai
Journal:  J Clin Exp Hepatol       Date:  2019-01-25

Review 3.  Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.

Authors:  Letiția Adela Maria Streba; Cristin Constantin Vere; Ion Rogoveanu; Costin Teodor Streba
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

4.  What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?

Authors:  Mariana V Machado; Sara Policarpo; J Coutinho; Sofia Carvalhana; Jorge Leitão; Armando Carvalho; Ana P Silva; Francisco Velasco; Isabel Medeiros; Ana Catarina Alves; Mafalda Bourbon; Helena Cortez-Pinto
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

Review 5.  Comorbidities as an Indication for Metabolic Surgery.

Authors:  Anne-Catherine Schwarz; Adrian T Billeter; Katharina M Scheurlen; Matthias Blüher; Beat P Müller-Stich
Journal:  Visc Med       Date:  2018-10-28

6.  Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitis.

Authors:  Daniel Ferraz de Campos Mazo; Rejane Mattar; José Tadeu Stefano; Joyce Matie Kinoshita da Silva-Etto; Márcio Augusto Diniz; Sebastião Mauro Bezerra Duarte; Fabíola Rabelo; Rodrigo Vieira Costa Lima; Priscila Brizolla de Campos; Flair José Carrilho; Claudia P Oliveira
Journal:  World J Hepatol       Date:  2016-08-28

Review 7.  Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.

Authors:  Akshay Shetty; Jennifer W Hsu; Paul P Manka; Wing-Kin Syn
Journal:  Dig Dis Sci       Date:  2018-08-18       Impact factor: 3.199

Review 8.  Influence of cirrhosis in cardiac surgery outcomes.

Authors:  Juan C Lopez-Delgado; Francisco Esteve; Casimiro Javierre; Josep L Ventura; Rafael Mañez; Elisabet Farrero; Herminia Torrado; David Rodríguez-Castro; Maria L Carrio
Journal:  World J Hepatol       Date:  2015-04-18

Review 9.  Outcomes of abdominal surgery in patients with liver cirrhosis.

Authors:  Juan C Lopez-Delgado; Josep Ballus; Francisco Esteve; Nelson L Betancur-Zambrano; Vicente Corral-Velez; Rafael Mañez; Antoni J Betbese; Joan A Roncal; Casimiro Javierre
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

10.  Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.

Authors:  Wei-Dong Li; Kun-Fa Fu; Gui-Mei Li; Yan-Shu Lian; Ai-Min Ren; Yun-Jue Chen; Jin-Rong Xia
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.